Recently, an ultrasensitive methodology of measuring plasma tau has been developed which has shown raised concentrations in Alzheimer’s disease,2 but has yet to be examined in FTD. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.